The talk show host revealed what life is like under her guardianship during a prerecorded interview on 'The View.' ...

Altimmune said on Thursday that it plans to test its lead experimental obesity drug, pemvidutide, to potentially treat ...

But the newest study that has gone viral is an even more impressive outcome. Headlines are claiming that researchers have ...

A new research report shows that 1 in 5 people using drugs and alcohol have symptoms of ADHD and that this rate increases to ...

GLP-1 receptor agonists show promise in treating alcohol addiction by modulating reward pathways and reducing cravings, offering a novel therapeutic approach.

The Maryland-based biopharma joins Eli Lilly and Novo Nordisk in trialing a GLP-1 agonist for alcohol- and liver-related ...